ANI Pharmaceuticals Ownership 2024 | Who Owns ANI Pharmaceuticals Now?
Institutional Ownership
79.18%
Insider Ownership
11.16%
Retail Ownership
9.66%
Institutional Holders
201.00
ANI Pharmaceuticals Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BLACKROCK INC. | 13.91% | 0.00% | 2,656,515 | 125,172 | 4.94% | 169,166,875 | Jun 30, 2024 |
| VANGUARD GROUP INC | 7.54% | 0.00% | 1,440,444 | 134,012 | 10.26% | 91,727,474 | Jun 30, 2024 |
| STATE STREET CORP | 3.38% | 0.00% | 645,145 | 70,307 | 12.23% | 41,082,834,000 | Jun 30, 2024 |
| DIMENSIONAL FUND ADVISORS LP | 3.30% | 0.01% | 630,226 | 21,053 | 3.46% | 40,132,138 | Jun 30, 2024 |
| RUBRIC CAPITAL MANAGEMENT LP | 3.16% | 1.01% | 603,800 | -354,733 | -37.01% | 38,449,984 | Jun 30, 2024 |
| GLOBAL ALPHA CAPITAL MANAGEMENT LTD. | 2.76% | 2.45% | 526,950 | 136,200 | 34.86% | 33,556,176 | Jun 30, 2024 |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 2.56% | 0.08% | 489,386 | -879 | -0.18% | 31,164,100 | Jun 30, 2024 |
| DEEP TRACK CAPITAL, LP | 2.44% | 0.89% | 466,089 | -355,912 | -43.30% | 29,680,548 | Jun 30, 2024 |
| TANG CAPITAL MANAGEMENT LLC | 2.36% | 2.92% | 450,000 | 300,000 | 200.00% | 28,656,000 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.14% | 0.00% | 407,911 | 68,547 | 20.20% | 25,980,646 | Jun 30, 2024 |
| RANGER INVESTMENT MANAGEMENT, L.P. | 2.11% | 1.74% | 402,734 | 530 | 0.13% | 25,646,101 | Jun 30, 2024 |
| MACQUARIE GROUP LTD | 2.03% | 0.03% | 388,077 | 174,178 | 81.43% | 24,713,000 | Jun 30, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | 1.67% | 0.01% | 319,142 | 72,986 | 29.65% | 20,322,962 | Jun 30, 2024 |
| INVESCO LTD. | 1.63% | 0.00% | 311,091 | -12,951 | -4.00% | 19,810,275 | Jun 30, 2024 |
| MORGAN STANLEY | 1.42% | 0.00% | 270,339 | 18,079 | 7.17% | 17,215,187 | Jun 30, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1.26% | 0.00% | 241,477 | 44,994 | 22.90% | 15,377,255 | Jun 30, 2024 |
| AMERIPRISE FINANCIAL INC | 1.22% | 0.00% | 233,354 | -9,920 | -4.08% | 14,859,981 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 1.20% | 0.01% | 230,079 | 209,272 | 1005.78% | 14,651,431 | Jun 30, 2024 |
| JPMORGAN CHASE & CO | 1.12% | 0.00% | 213,981 | -18,209 | -7.84% | 13,626,309 | Jun 30, 2024 |
| KENNEDY CAPITAL MANAGEMENT LLC | 1.04% | 0.27% | 198,054 | -11,972 | -5.70% | 12,612,079 | Jun 30, 2024 |
ANI Pharmaceuticals's largest institutional shareholder is BLACKROCK INC., holding 13.91% of the company's total share outstanding, currently valued at $169.17M. The top 10 institutional shareholders own together 43.54% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 2.36% | 2.92% | 450,000 | 300,000 | 200.00% | 28,656,000 | Jun 30, 2024 |
| GLOBAL ALPHA CAPITAL MANAGEMENT LTD. | 2.76% | 2.45% | 526,950 | 136,200 | 34.86% | 33,556,176 | Jun 30, 2024 |
| RANGER INVESTMENT MANAGEMENT, L.P. | 2.11% | 1.74% | 402,734 | 530 | 0.13% | 25,646,101 | Jun 30, 2024 |
| SIO CAPITAL MANAGEMENT, LLC | 0.38% | 1.24% | 71,740 | -15,614 | -17.87% | 4,568,403 | Jun 30, 2024 |
| MARATHON CAPITAL MANAGEMENT | 0.37% | 1.14% | 70,295 | -875 | -1.23% | 4,476,386 | Jun 30, 2024 |
| RUBRIC CAPITAL MANAGEMENT LP | 3.16% | 1.01% | 603,800 | -354,733 | -37.01% | 38,449,984 | Jun 30, 2024 |
| DEEP TRACK CAPITAL, LP | 2.44% | 0.89% | 466,089 | -355,912 | -43.30% | 29,680,548 | Jun 30, 2024 |
| LISANTI CAPITAL GROWTH, LLC | 0.27% | 0.78% | 51,105 | 19,020 | 59.28% | 3,254,366 | Jun 30, 2024 |
| HUSSMAN STRATEGIC ADVISORS, INC. | 0.22% | 0.74% | 42,000 | 10,500 | 33.33% | 2,674,560 | Jun 30, 2024 |
| VIRTUS INVESTMENT ADVISERS, INC. | 0.06% | 0.66% | 12,319 | - | - | 784,474 | Jun 30, 2024 |
| PERKINS CAPITAL MANAGEMENT INC | 0.05% | 0.55% | 9,191 | - | - | 585,000 | Jun 30, 2024 |
| KINGS PATH PARTNERS LLC | 0.09% | 0.49% | 16,332 | 16,332 | 100.00% | 1,040,022 | Jun 30, 2024 |
| QUANTEDGE CAPITAL PTE LTD | 0.11% | 0.49% | 21,200 | 21,200 | 100.00% | 1,350,016 | Jun 30, 2024 |
| CITY CENTER ADVISORS, LLC | 0.03% | 0.41% | 5,021 | - | - | 347,102 | Jun 30, 2024 |
| JACKSON CREEK INVESTMENT ADVISORS LLC | 0.08% | 0.35% | 14,913 | -34 | -0.23% | 950,000 | Jun 30, 2024 |
| WAKEFIELD ASSET MANAGEMENT LLLP | 0.07% | 0.31% | 13,986 | -177 | -1.25% | 890,629 | Jun 30, 2024 |
| 1492 CAPITAL MANAGEMENT LLC | 0.04% | 0.29% | 8,178 | - | - | 520,775 | Jun 30, 2024 |
| CLARIVEST ASSET MANAGEMENT LLC | 0.23% | 0.29% | 43,911 | -6,199 | -12.37% | 2,796,253 | Jun 30, 2024 |
| KENNEDY CAPITAL MANAGEMENT LLC | 1.04% | 0.27% | 198,054 | -11,972 | -5.70% | 12,612,079 | Jun 30, 2024 |
| ENTRYPOINT CAPITAL, LLC | 0.01% | 0.25% | 2,724 | 2,724 | 100.00% | 173,464 | Jun 30, 2024 |
The largest ANI Pharmaceuticals shareholder by % of total assets is TANG CAPITAL MANAGEMENT LLC. The company owns 450.00K shares of ANI Pharmaceuticals (ANIP), representing 2.92% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 2.36% | 2.92% | 450,000 | 300,000 | 200.00% | 28,656,000 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 1.20% | 0.01% | 230,079 | 209,272 | 1005.78% | 14,651,431 | Jun 30, 2024 |
| MACQUARIE GROUP LTD | 2.03% | 0.03% | 388,077 | 174,178 | 81.43% | 24,713,000 | Jun 30, 2024 |
| GLOBAL ALPHA CAPITAL MANAGEMENT LTD. | 2.76% | 2.45% | 526,950 | 136,200 | 34.86% | 33,556,176 | Jun 30, 2024 |
| VANGUARD GROUP INC | 7.54% | 0.00% | 1,440,444 | 134,012 | 10.26% | 91,727,474 | Jun 30, 2024 |
| BLACKROCK INC. | 13.91% | 0.00% | 2,656,515 | 125,172 | 4.94% | 169,166,875 | Jun 30, 2024 |
| WEISS ASSET MANAGEMENT LP | 0.40% | 0.18% | 76,511 | 76,511 | 100.00% | 4,872,220 | Jun 30, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | 1.67% | 0.01% | 319,142 | 72,986 | 29.65% | 20,322,962 | Jun 30, 2024 |
| STATE STREET CORP | 3.38% | 0.00% | 645,145 | 70,307 | 12.23% | 41,082,834,000 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.14% | 0.00% | 407,911 | 68,547 | 20.20% | 25,980,646 | Jun 30, 2024 |
| FIRST TRUST ADVISORS LP | 0.32% | 0.00% | 61,779 | 61,779 | 100.00% | 3,934,086 | Jun 30, 2024 |
| AMERICAN CENTURY COMPANIES INC | 0.52% | 0.00% | 99,831 | 49,717 | 99.21% | 6,357,238 | Jun 30, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1.26% | 0.00% | 241,477 | 44,994 | 22.90% | 15,377,255 | Jun 30, 2024 |
| SEGALL BRYANT & HAMILL, LLC | 0.23% | 0.05% | 44,132 | 44,132 | 100.00% | 2,810,326 | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | 0.82% | 0.02% | 156,995 | 39,469 | 33.58% | 9,997,441 | Jun 30, 2024 |
| UBS ASSET MANAGEMENT AMERICAS INC | 0.23% | 0.00% | 42,971 | 27,435 | 176.59% | 2,736,393 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 0.47% | 0.00% | 89,959 | 24,169 | 36.74% | 5,728,589 | Jun 30, 2024 |
| QUANTEDGE CAPITAL PTE LTD | 0.11% | 0.49% | 21,200 | 21,200 | 100.00% | 1,350,016 | Jun 30, 2024 |
| DIMENSIONAL FUND ADVISORS LP | 3.30% | 0.01% | 630,226 | 21,053 | 3.46% | 40,132,138 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.82% | 0.02% | 156,802 | 20,900 | 15.38% | 9,985,151 | Jun 30, 2024 |
As of Jun 30 2024, ANI Pharmaceuticals's largest institutional buyer is TANG CAPITAL MANAGEMENT LLC. The company purchased 300.00K stocks of ANIP, valued at $28.66M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| DEEP TRACK CAPITAL, LP | 2.44% | 0.89% | 466,089 | -355,912 | -43.30% | 29,680,548 | Jun 30, 2024 |
| RUBRIC CAPITAL MANAGEMENT LP | 3.16% | 1.01% | 603,800 | -354,733 | -37.01% | 38,449,984 | Jun 30, 2024 |
| HILLSDALE INVESTMENT MANAGEMENT INC. | 0.00% | 0.00% | 90 | -67,420 | -99.87% | 5,731 | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | - | - | - | -55,683 | -100.00% | - | Jun 30, 2024 |
| TREXQUANT INVESTMENT LP | 0.09% | 0.02% | 16,772 | -30,375 | -64.43% | 1,068,041 | Jun 30, 2024 |
| ALGERT GLOBAL LLC | 0.07% | 0.03% | 12,951 | -23,629 | -64.60% | 825,000 | Jun 30, 2024 |
| WEDGE CAPITAL MANAGEMENT L L P/NC | 0.32% | 0.07% | 61,961 | -18,900 | -23.37% | 3,945,676 | Jun 30, 2024 |
| JPMORGAN CHASE & CO | 1.12% | 0.00% | 213,981 | -18,209 | -7.84% | 13,626,309 | Jun 30, 2024 |
| SIO CAPITAL MANAGEMENT, LLC | 0.38% | 1.24% | 71,740 | -15,614 | -17.87% | 4,568,403 | Jun 30, 2024 |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | - | - | - | -13,346 | -100.00% | - | Jun 30, 2024 |
| COMERICA BANK | 0.12% | 0.01% | 23,563 | -13,100 | -35.73% | 1,500,467 | Jun 30, 2024 |
| INVESCO LTD. | 1.63% | 0.00% | 311,091 | -12,951 | -4.00% | 19,810,275 | Jun 30, 2024 |
| INSPIRE INVESTING, LLC | - | - | - | -12,520 | -100.00% | - | Jun 30, 2024 |
| BNP PARIBAS ARBITRAGE, SNC | 0.04% | 0.00% | 8,297 | -12,442 | -59.99% | 528,353 | Jun 30, 2024 |
| KENNEDY CAPITAL MANAGEMENT LLC | 1.04% | 0.27% | 198,054 | -11,972 | -5.70% | 12,612,079 | Jun 30, 2024 |
| AMERIPRISE FINANCIAL INC | 1.22% | 0.00% | 233,354 | -9,920 | -4.08% | 14,859,981 | Jun 30, 2024 |
| ASSENAGON ASSET MANAGEMENT S.A. | 0.39% | 0.01% | 74,566 | -9,378 | -11.17% | 4,748,363 | Jun 30, 2024 |
| BOSTON PARTNERS | - | - | - | -8,762 | -100.00% | - | Jun 30, 2024 |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 0.04% | 0.00% | 6,742 | -8,560 | -55.94% | 429,331 | Jun 30, 2024 |
| MML INVESTORS SERVICES, LLC | - | - | - | -7,974 | -100.00% | - | Jun 30, 2024 |
As of Jun 30 2024, ANI Pharmaceuticals's biggest institutional seller is DEEP TRACK CAPITAL, LP. The company sold -0.36M shares of ANIP, valued at $29.68M.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| WEISS ASSET MANAGEMENT LP | 0.40% | 0.18% | 76,511 | 76,511 | 100.00% | 4,872,220 | Jun 30, 2024 |
| FIRST TRUST ADVISORS LP | 0.32% | 0.00% | 61,779 | 61,779 | 100.00% | 3,934,086 | Jun 30, 2024 |
| SEGALL BRYANT & HAMILL, LLC | 0.23% | 0.05% | 44,132 | 44,132 | 100.00% | 2,810,326 | Jun 30, 2024 |
| QUANTEDGE CAPITAL PTE LTD | 0.11% | 0.49% | 21,200 | 21,200 | 100.00% | 1,350,016 | Jun 30, 2024 |
| KINGS PATH PARTNERS LLC | 0.09% | 0.49% | 16,332 | 16,332 | 100.00% | 1,040,022 | Jun 30, 2024 |
| NATIXIS ADVISORS, L.P. | 0.06% | 0.00% | 11,639 | 11,639 | 100.00% | 741,000 | Jun 30, 2024 |
| WALLEYE CAPITAL LLC | 0.06% | 0.00% | 10,849 | 10,849 | 100.00% | 690,864 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.06% | 0.00% | 10,594 | 10,594 | 100.00% | 674,626 | Jun 30, 2024 |
| SEQUOIA FINANCIAL ADVISORS, LLC | 0.05% | 0.01% | 9,423 | 9,423 | 100.00% | 600,058 | Jun 30, 2024 |
| D. E. SHAW & CO., INC. | 0.05% | 0.00% | 8,760 | 8,760 | 100.00% | 557,837 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.04% | 0.00% | 8,135 | 8,135 | 100.00% | 518,037 | Jun 30, 2024 |
| NEUBERGER BERMAN GROUP LLC | 0.03% | 0.00% | 5,525 | 5,525 | 100.00% | 351,832 | Jun 30, 2024 |
| SHERBROOKE PARK ADVISERS LLC | 0.03% | 0.06% | 5,280 | 5,280 | 100.00% | 336,230 | Jun 30, 2024 |
| MARSHALL WACE, LLP | 0.02% | 0.00% | 3,979 | 3,979 | 100.00% | 253,383 | Jun 30, 2024 |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 0.02% | 0.01% | 3,588 | 3,588 | 100.00% | 228,484 | Jun 30, 2024 |
| PROFUND ADVISORS LLC | 0.02% | 0.01% | 3,536 | 3,536 | 100.00% | 225,172 | Jun 30, 2024 |
| RIDGEWOOD INVESTMENTS LLC | 0.01% | 0.04% | 1,329 | 1,329 | 100.00% | 84,631 | Jun 30, 2024 |
| INNEALTA CAPITAL, LLC | 0.01% | 0.02% | 1,025 | 1,025 | 100.00% | 65,272 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL INVESTMENTS CO., LTD. | 0.00% | 0.00% | 626 | 626 | 100.00% | 39,494 | Jun 30, 2024 |
| COPPELL ADVISORY SOLUTIONS LLC | 0.00% | 0.01% | 599 | 599 | 100.00% | 38,144 | Jun 30, 2024 |
| QUARRY LP | 0.00% | 0.00% | 142 | 142 | 100.00% | 9,043 | Jun 30, 2024 |
| SMARTLEAF ASSET MANAGEMENT LLC | 0.00% | 0.00% | 25 | 25 | 100.00% | 1,577 | Jun 30, 2024 |
| ROTHSCHILD INVESTMENT LLC | - | - | 5 | 5 | 100.00% | 318 | Jun 30, 2024 |
ANI Pharmaceuticals's largest new institutional shareholder by number of shares is WEISS ASSET MANAGEMENT LP, purchased 76.51K shares, valued at $4.87M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| CUBIST SYSTEMATIC STRATEGIES, LLC | - | - | - | -55,683 | -100.00% | - | Jun 30, 2024 |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | - | - | - | -13,346 | -100.00% | - | Jun 30, 2024 |
| INSPIRE INVESTING, LLC | - | - | - | -12,520 | -100.00% | - | Jun 30, 2024 |
| BOSTON PARTNERS | - | - | - | -8,762 | -100.00% | - | Jun 30, 2024 |
| MML INVESTORS SERVICES, LLC | - | - | - | -7,974 | -100.00% | - | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -7,946 | -100.00% | - | Jun 30, 2024 |
| RAYMOND JAMES & ASSOCIATES | - | - | - | -7,456 | -100.00% | - | Jun 30, 2024 |
| CASTLEKNIGHT MANAGEMENT LP | - | - | - | -6,000 | -100.00% | - | Jun 30, 2024 |
| ZACKS INVESTMENT MANAGEMENT | - | - | - | -5,339 | -100.00% | - | Jun 30, 2024 |
| NEW YORK LIFE INVESTMENT MANAGEMENT LLC | - | - | - | -5,127 | -100.00% | - | Jun 30, 2024 |
| ENTROPY TECHNOLOGIES, LP | - | - | - | -4,913 | -100.00% | - | Jun 30, 2024 |
| VERSOR INVESTMENTS LP | - | - | - | -4,745 | -100.00% | - | Jun 30, 2024 |
| GRAHAM CAPITAL MANAGEMENT, L.P. | - | - | - | -3,334 | -100.00% | - | Jun 30, 2024 |
| GROUP ONE TRADING, L.P. | - | - | - | -3,312 | -100.00% | - | Jun 30, 2024 |
| STRS OHIO | - | - | - | -3,300 | -100.00% | - | Jun 30, 2024 |
| ROBECO INSTITUTIONAL ASSET MANAGEMENT B.V. | - | - | - | -3,254 | -100.00% | - | Jun 30, 2024 |
| WOLVERINE TRADING, LLC | - | - | - | -3,200 | -100.00% | - | Jun 30, 2024 |
| HIGHTOWER ADVISORS, LLC | - | - | - | -2,887 | -100.00% | - | Jun 30, 2024 |
| METROPOLITAN LIFE INSURANCE CO/NY | - | - | - | -847 | -100.00% | - | Jun 30, 2024 |
| QUANTBOT TECHNOLOGIES LP | - | - | - | -719 | -100.00% | - | Jun 30, 2024 |
| TRUVESTMENTS CAPITAL LLC | - | - | - | -267 | -100.00% | - | Jun 30, 2024 |
| HEADLANDS TECHNOLOGIES LLC | - | - | - | -194 | -100.00% | - | Jun 30, 2024 |
| FERNWOOD INVESTMENT MANAGEMENT, LLC | - | - | - | -55 | -100.00% | - | Jun 30, 2024 |
| BENJAMIN F. EDWARDS & COMPANY, INC. | - | - | - | -23 | -100.00% | - | Jun 30, 2024 |
| FINANCIAL SYNERGIES WEALTH ADVISORS, INC. | - | - | - | -16 | -100.00% | - | Jun 30, 2024 |
| YHB INVESTMENT ADVISORS, INC. | - | - | - | -15 | -100.00% | - | Jun 30, 2024 |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | - | - | - | -3 | -100.00% | - | Jun 30, 2024 |
| FARTHER FINANCE ADVISORS, LLC | - | - | - | -3 | -100.00% | - | Jun 30, 2024 |
| FIFTH THIRD BANCORP | - | - | - | -2 | -100.00% | - | Jun 30, 2024 |
| FINANCIAL GRAVITY ASSET MANAGEMENT, INC. | - | - | - | -1 | -100.00% | - | Jun 30, 2024 |
ANI Pharmaceuticals's largest sold out institutional shareholder by shares sold is CUBIST SYSTEMATIC STRATEGIES, LLC, sold -55.68K shares, valued at -, as of undefined.
ANI Pharmaceuticals Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| Walthausen Funds | 1.13% | 38,770 | - | - | Apr 30, 2023 |
| HIGHLAND FUNDS II | 0.48% | 7,100 | - | - | Dec 31, 2023 |
| RANGER FUNDS INVESTMENT TRUST | 0.45% | 10,332 | 320 | 3.20% | Jan 31, 2024 |
| CORNERCAP GROUP OF FUNDS /VA/ | 0.29% | 20,851 | - | - | Sep 30, 2022 |
| Federated Hermes MDT Series | 0.09% | 218,631 | - | - | Jan 31, 2024 |
| Vanguard Montgomery Funds | 0.08% | 19,774 | 2,635 | 15.37% | Mar 31, 2024 |
| Zacks Trust | 0.06% | 5,300 | 5,300 | - | Feb 29, 2024 |
| OBERWEIS FUNDS | 0.04% | 43,500 | - | - | Mar 31, 2024 |
| STATE STREET INSTITUTIONAL FUNDS | 0.03% | 21,855 | -6,247 | -22.23% | Mar 31, 2024 |
| DEUTSCHE DWS INVESTMENT TRUST | 0.03% | 83,019 | - | - | Jan 31, 2024 |
| SYNTAX ETF TRUST | 0.03% | 836 | -236 | -22.01% | Mar 31, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.02% | 11,494 | - | - | Mar 31, 2024 |
| VANGUARD ADMIRAL FUNDS | 0.02% | 81,873 | -11,775 | -12.57% | Feb 29, 2024 |
| Vericimetry Funds | 0.02% | 1,450 | - | - | Mar 31, 2024 |
| BNY MELLON INDEX FUNDS, INC. | 0.01% | 15,411 | -2,884 | -15.76% | Jan 31, 2024 |
| BNY MELLON INVESTMENT PORTFOLIOS | 0.01% | 7,574 | 36 | 0.48% | Mar 31, 2024 |
| World Funds Trust | 0.01% | 7,100 | - | - | Jan 31, 2024 |
| BNY Mellon Strategic Funds, Inc. | 0.01% | 25,870 | - | - | Mar 31, 2024 |
| FRONTIER FUNDS, INC. | 0.01% | 3,839 | - | - | Mar 31, 2024 |
| DELAWARE GROUP EQUITY FUNDS IV | 0.01% | 11,122 | -3,038 | -21.45% | Mar 28, 2024 |
| HUSSMAN INVESTMENT TRUST | 0.01% | 30,400 | - | - | Dec 31, 2023 |
| VANGUARD EXPLORER FUND | 0.01% | 103,131 | 28,809 | 38.76% | Jan 31, 2024 |
| Humankind Benefit Corp | 0.00% | 106 | 13 | 13.98% | Dec 31, 2023 |
| FORUM FUNDS II | 0.00% | 4,403 | 46 | 1.06% | Mar 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.00% | 25,640 | -798 | -3.02% | Mar 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.00% | 2,216 | -40 | -1.77% | Mar 31, 2024 |
| AMERICAN CENTURY QUANTITATIVE EQUITY FUNDS, INC. | 0.00% | 6,443 | - | - | Mar 31, 2024 |
| GOLDMAN SACHS VARIABLE INSURANCE TRUST | 0.00% | 10,953 | - | - | Mar 31, 2024 |
| INVESCO EXCHANGE-TRADED FUND TRUST | 0.00% | 206,867 | -20,292 | -8.93% | Jan 31, 2024 |
| DEUTSCHE DWS VARIABLE SERIES II | 0.00% | 5,965 | - | - | Mar 31, 2024 |
| WILLIAM BLAIR FUNDS | 0.00% | 194,910 | 1,040 | 0.54% | Mar 31, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 82,248 | 15,784 | 23.75% | Jan 31, 2024 |
| VANGUARD INDEX FUNDS | 0.00% | 742,991 | -233,582 | -23.92% | Mar 31, 2024 |
| AMG FUNDS III | 0.00% | 8,770 | - | - | Mar 28, 2024 |
| Securian Funds Trust | 0.00% | 15,996 | 115 | 0.72% | Mar 31, 2024 |
| Columbia Funds Variable Series Trust II | 0.00% | 47,272 | -1,520 | -3.12% | Mar 31, 2024 |
| FIRST TRUST EXCHANGE-TRADED ALPHADEX FUND | 0.00% | 5,358 | - | - | Jan 31, 2024 |
| JNL VARIABLE FUND LLC | 0.00% | 7,506 | - | - | Mar 31, 2020 |
| Fidelity Commonwealth Trust II | 0.00% | 8,761 | - | - | Aug 31, 2023 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.00% | 292 | - | - | Mar 31, 2024 |
| FORUM FUNDS | 0.00% | 2,925 | 2,925 | - | Mar 31, 2024 |
| PFM Multi-Manager Series Trust | 0.00% | 1,003 | - | - | Dec 31, 2023 |
| UNIFIED SERIES TRUST | 0.00% | 19,000 | 2,000 | 11.76% | Feb 29, 2024 |
| SSGA FUNDS | 0.00% | 519 | - | - | Feb 29, 2024 |
| CULLEN FUNDS TRUST | 0.00% | 2,704 | - | - | Mar 31, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 2,774 | 376 | 15.68% | Mar 31, 2024 |
| FINANCIAL INVESTORS TRUST | 0.00% | 77,648 | - | - | Jan 31, 2024 |
| Ivy Variable Insurance Portfolios | 0.00% | 22,248 | - | - | Mar 28, 2024 |
| Principal Exchange-Traded Funds | 0.00% | 9,232 | 6,495 | 237.30% | Mar 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 144,550 | -4,642 | -3.11% | Feb 29, 2024 |
| AMERICAN PENSION INVESTORS TRUST | 0.00% | 4,050 | - | - | Jan 31, 2024 |
| Legg Mason ETF Investment Trust | 0.00% | 1,311 | -147 | -10.08% | Mar 31, 2024 |
| RYDEX VARIABLE TRUST | 0.00% | 767 | 759 | 9487.50% | Dec 31, 2023 |
| VANGUARD VARIABLE INSURANCE FUNDS | 0.00% | 33,191 | - | - | Mar 31, 2024 |
| VANGUARD HORIZON FUNDS | 0.00% | 14,611 | -14,611 | -50.00% | Mar 31, 2024 |
| FIDELITY COVINGTON TRUST | 0.00% | 10,988 | -224 | -2.00% | Jan 31, 2024 |
| VANGUARD TAX-MANAGED FUNDS | 0.00% | 113,437 | -4,342 | -3.69% | Mar 31, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 1,456 | - | - | Mar 31, 2024 |
| AdvisorShares Trust | 0.00% | 1,856 | - | - | Mar 28, 2024 |
| SHELTON FUNDS | 0.00% | 753 | - | - | Feb 29, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 454,231 | 63,773 | 16.33% | Jan 31, 2024 |
| IVY FUNDS | 0.00% | 138,860 | -8,030 | -5.47% | Mar 28, 2024 |
| Capitol Series Trust | 0.00% | 3,915 | - | - | Jan 31, 2024 |
| Virtus Investment Trust | 0.00% | 12,319 | - | - | Mar 28, 2024 |
| STEWARD FUNDS, INC. | 0.00% | 800 | - | - | Jan 31, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 9,420 | -790 | -7.74% | Mar 31, 2024 |
| VALIC Co II | 0.00% | 9,800 | 200 | 2.08% | Feb 28, 2021 |
| ADVISORS' INNER CIRCLE FUND | 0.00% | 6,706 | -1,494 | -18.22% | Jan 31, 2024 |
| FundVantage Trust | 0.00% | 4,108 | -278 | -6.34% | Mar 28, 2024 |
| Dimensional ETF Trust | 0.00% | 113,653 | 18,417 | 19.34% | Jan 31, 2024 |
| Managed Portfolio Series | 0.00% | 5,680 | - | - | Mar 31, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 1,217 | -136 | -10.05% | Mar 31, 2024 |
| RBB FUND, INC. | 0.00% | 23,518 | 9,653 | 69.62% | Feb 29, 2024 |
| Investment Managers Series Trust II | 0.00% | 2,940 | 487 | 19.85% | Mar 31, 2024 |
| CLEARWATER INVESTMENT TRUST | 0.00% | 2,089 | 1,389 | 198.43% | Mar 28, 2024 |
| VANGUARD WORLD FUND | 0.00% | 51,621 | 51,601 | 258005.00% | Feb 29, 2024 |
| Virtus Strategy Trust | 0.00% | 4,351 | - | - | Mar 28, 2024 |
| PRUDENTIAL SERIES FUND | 0.00% | 15,330 | -600 | -3.77% | Mar 28, 2024 |
| ALLIANZ VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 10,477 | -1,292 | -10.98% | Dec 31, 2023 |
| TIMOTHY PLAN | 0.00% | 861 | - | - | Mar 31, 2024 |
| Horizon Funds | 0.00% | 353 | 96 | 37.35% | Feb 29, 2024 |
| RUSSELL INVESTMENT CO | 0.00% | 53,493 | -6,567 | -10.93% | Jan 31, 2024 |
| NORTHERN LIGHTS FUND TRUST II | 0.00% | 1,861 | - | - | Feb 29, 2024 |
| VICTORY PORTFOLIOS | 0.00% | 5,073 | - | - | Mar 31, 2024 |
| PRAXIS MUTUAL FUNDS | 0.00% | 1,780 | - | - | Dec 31, 2023 |
| Global X Funds | 0.00% | 7,134 | - | - | Jan 31, 2024 |
| AMERICAN CENTURY ETF TRUST | 0.00% | 18,033 | 11,180 | 163.14% | Feb 29, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 4,844 | -927 | -16.06% | Mar 31, 2024 |
| SunAmerica Specialty Series | 0.00% | 78 | - | - | Apr 30, 2021 |
| Mutual of America Variable Insurance Portfolios, Inc. | 0.00% | 102 | 2 | 2.00% | Sep 30, 2023 |
| GPS Funds I | 0.00% | 760 | - | - | Mar 31, 2024 |
| SCHWAB STRATEGIC TRUST | 0.00% | 79,245 | -2,192 | -2.69% | Feb 29, 2024 |
| Invesco Exchange-Traded Fund Trust II | 0.00% | 41,307 | -43,286 | -51.17% | Feb 29, 2024 |
| ProFunds | 0.00% | 1,514 | -1,160 | -43.38% | Mar 31, 2024 |
| Dunham Funds | 0.00% | 8,200 | - | - | Jan 31, 2024 |
| RUSSELL INVESTMENT FUNDS | 0.00% | 13,596 | 577 | 4.43% | Mar 31, 2024 |
| THRIVENT SERIES FUND INC | 0.00% | 13,078 | -356 | -2.65% | Mar 28, 2024 |
| CALAMOS INVESTMENT TRUST/IL | 0.00% | 12,090 | - | - | Jan 31, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 494 | 377 | 322.22% | Dec 31, 2023 |
| Guggenheim Variable Funds Trust | 0.00% | 454 | - | - | Dec 31, 2023 |
ANI Pharmaceuticals's largest mutual fund holder by % of total assets is "Walthausen Funds", owning 38.77K shares, compromising 1.13% of its total assets.
ANI Pharmaceuticals Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 201 | -2.43% |
| 31 Mar, 24 | 206 | 12.57% |
| 31 Dec, 23 | 183 | -2.66% |
| 30 Sep, 23 | 188 | 8.67% |
| 30 Jun, 23 | 173 | 23.57% |
| 31 Mar, 23 | 140 | 10.24% |
| 31 Dec, 22 | 127 | 5.83% |
| 30 Sep, 22 | 120 | 5.26% |
| 30 Jun, 22 | 114 | -5.79% |
| 31 Mar, 22 | 121 | -8.33% |
| 31 Dec, 21 | 132 | 15.79% |
| 30 Sep, 21 | 114 | 0.88% |
| 30 Jun, 21 | 113 | 6.60% |
| 31 Mar, 21 | 106 | -9.40% |
| 31 Dec, 20 | 117 | 2.63% |
| 30 Sep, 20 | 114 | -13.64% |
| 30 Jun, 20 | 132 | -9.59% |
| 31 Mar, 20 | 146 | -16.57% |
| 31 Dec, 19 | 175 | -12.94% |
| 30 Sep, 19 | 201 | -0.99% |
| 30 Jun, 19 | 203 | 4.10% |
| 31 Mar, 19 | 195 | 14.71% |
| 31 Dec, 18 | 170 | -4.49% |
| 30 Sep, 18 | 178 | -6.32% |
| 30 Jun, 18 | 190 | 3.83% |
| 31 Mar, 18 | 183 | 7.02% |
| 31 Dec, 17 | 171 | 13.25% |
| 30 Sep, 17 | 151 | -5.63% |
| 30 Jun, 17 | 160 | -5.88% |
| 31 Mar, 17 | 170 | 2.41% |
| 31 Dec, 16 | 166 | -8.29% |
| 30 Sep, 16 | 181 | 21.48% |
| 30 Jun, 16 | 149 | 16.41% |
| 31 Mar, 16 | 128 | -1.54% |
| 31 Dec, 15 | 130 | 3.17% |
| 30 Sep, 15 | 126 | -4.55% |
| 30 Jun, 15 | 132 | -0.75% |
| 31 Mar, 15 | 133 | 30.39% |
| 31 Dec, 14 | 102 | 45.71% |
| 30 Sep, 14 | 70 | -11.39% |
| 30 Jun, 14 | 79 | 19.70% |
| 31 Mar, 14 | 66 | 94.12% |
| 31 Dec, 13 | 34 | 21.43% |
| 30 Sep, 13 | 28 | 2700.00% |
| 30 Jun, 13 | 1 | - |
As of 30 Jun 24, 201 institutions are holding ANI Pharmaceuticals's shares, representing a decrease of -2.43% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 15,122,877 | 7.14% |
| 31 Mar, 24 | 14,115,555 | 3.76% |
| 31 Dec, 23 | 13,603,494 | 3.16% |
| 30 Sep, 23 | 13,186,506 | 7.85% |
| 30 Jun, 23 | 12,226,770 | 18.11% |
| 31 Mar, 23 | 10,351,783 | 1.13% |
| 31 Dec, 22 | 10,235,727 | -0.20% |
| 30 Sep, 22 | 10,256,276 | 3.95% |
| 30 Jun, 22 | 9,866,909 | 7.33% |
| 31 Mar, 22 | 9,192,939 | 2.77% |
| 31 Dec, 21 | 8,945,507 | 22.34% |
| 30 Sep, 21 | 7,312,182 | 1.37% |
| 30 Jun, 21 | 7,213,353 | -1.09% |
| 31 Mar, 21 | 7,293,187 | -0.88% |
| 31 Dec, 20 | 7,358,068 | 1.30% |
| 30 Sep, 20 | 7,263,569 | -2.22% |
| 30 Jun, 20 | 7,428,472 | -6.49% |
| 31 Mar, 20 | 7,943,670 | -1.62% |
| 31 Dec, 19 | 8,074,478 | -11.27% |
| 30 Sep, 19 | 9,100,263 | 6.31% |
| 30 Jun, 19 | 8,560,117 | 11.23% |
| 31 Mar, 19 | 7,695,772 | 8.68% |
| 31 Dec, 18 | 7,081,024 | -5.63% |
| 30 Sep, 18 | 7,503,783 | 4.31% |
| 30 Jun, 18 | 7,193,512 | 8.62% |
| 31 Mar, 18 | 6,622,753 | 1.20% |
| 31 Dec, 17 | 6,544,504 | 2.04% |
| 30 Sep, 17 | 6,413,750 | -1.28% |
| 30 Jun, 17 | 6,496,986 | 0.68% |
| 31 Mar, 17 | 6,453,161 | 3.28% |
| 31 Dec, 16 | 6,248,132 | 3.56% |
| 30 Sep, 16 | 6,033,557 | 7.58% |
| 30 Jun, 16 | 5,608,466 | -3.40% |
| 31 Mar, 16 | 5,805,959 | -8.13% |
| 31 Dec, 15 | 6,319,843 | -54.56% |
| 30 Sep, 15 | 13,907,641 | 114.14% |
| 30 Jun, 15 | 6,494,752 | -6.68% |
| 31 Mar, 15 | 6,959,440 | -13.31% |
| 31 Dec, 14 | 8,027,767 | 77.40% |
| 30 Sep, 14 | 4,525,293 | -0.52% |
| 30 Jun, 14 | 4,549,048 | 20.01% |
| 31 Mar, 14 | 3,790,590 | 190.23% |
| 31 Dec, 13 | 1,306,043 | 20.21% |
| 30 Sep, 13 | 1,086,431 | 8232.80% |
| 30 Jun, 13 | 13,038 | - |
ANI Pharmaceuticals (ANIP) has 15.12M shares outstanding as of 30 Jun 24, up 7.14% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 79.18% | 1.45% |
| 31 Mar, 24 | 73.91% | 1.44% |
| 31 Dec, 23 | 71.59% | 1.47% |
| 30 Sep, 23 | 69.83% | 1.46% |
| 30 Jun, 23 | 69.12% | 1.73% |
| 31 Mar, 23 | 63.15% | 1.59% |
| 31 Dec, 22 | 62.95% | 1.59% |
| 30 Sep, 22 | 62.91% | 1.71% |
| 30 Jun, 22 | 60.64% | 1.87% |
| 31 Mar, 22 | 56.97% | 1.13% |
| 31 Dec, 21 | 71.02% | 1.92% |
| 30 Sep, 21 | 60.84% | 1.70% |
| 30 Jun, 21 | 59.83% | 1.62% |
| 31 Mar, 21 | 60.76% | 1.61% |
| 31 Dec, 20 | 61.34% | 1.67% |
| 30 Sep, 20 | 60.58% | 1.57% |
| 30 Jun, 20 | 62.07% | 1.39% |
| 31 Mar, 20 | 66.85% | 1.45% |
| 31 Dec, 19 | 67.93% | 1.16% |
| 30 Sep, 19 | 76.61% | 1.47% |
| 30 Jun, 19 | 72.23% | 1.68% |
| 31 Mar, 19 | 65.51% | 1.80% |
| 31 Dec, 18 | 60.37% | 1.47% |
| 30 Sep, 18 | 64.10% | 1.69% |
| 30 Jun, 18 | 61.59% | 1.89% |
| 31 Mar, 18 | 57.15% | 1.78% |
| 31 Dec, 17 | 56.68% | 1.84% |
| 30 Sep, 17 | 55.52% | 1.75% |
| 30 Jun, 17 | 56.27% | 1.80% |
| 31 Mar, 17 | 55.98% | 1.90% |
| 31 Dec, 16 | 54.25% | 1.96% |
| 30 Sep, 16 | 52.63% | 2.18% |
| 30 Jun, 16 | 49.19% | 1.89% |
| 31 Mar, 16 | 50.95% | 1.66% |
| 31 Dec, 15 | 55.33% | 0.37% |
| 30 Sep, 15 | 122.17% | 3.73% |
| 30 Jun, 15 | 57.25% | 1.52% |
| 31 Mar, 15 | 61.45% | 1.14% |
| 31 Dec, 14 | 73.37% | 4.52% |
| 30 Sep, 14 | 40.28% | 2.46% |
| 30 Jun, 14 | 40.50% | 2.81% |
| 31 Mar, 14 | 37.94% | 5.72% |
| 31 Dec, 13 | 25.76% | 5.61% |
| 30 Sep, 13 | 21.42% | 20990.36% |
| 30 Jun, 13 | 0.32% | - |
As of 30 Jun 24, ANI Pharmaceuticals is held by 79.18% institutional shareholders, representing a 1.45% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 105 | -2.78% |
| 31 Mar, 24 | 108 | 25.58% |
| 31 Dec, 23 | 86 | -16.50% |
| 30 Sep, 23 | 103 | -11.97% |
| 30 Jun, 23 | 117 | 98.31% |
| 31 Mar, 23 | 59 | -11.94% |
| 31 Dec, 22 | 67 | 36.73% |
| 30 Sep, 22 | 49 | -16.95% |
| 30 Jun, 22 | 59 | -10.61% |
| 31 Mar, 22 | 66 | -21.43% |
| 31 Dec, 21 | 84 | 104.88% |
| 30 Sep, 21 | 41 | -18.00% |
| 30 Jun, 21 | 50 | 19.05% |
| 31 Mar, 21 | 42 | -22.22% |
| 31 Dec, 20 | 54 | -3.57% |
| 30 Sep, 20 | 56 | -1.75% |
| 30 Jun, 20 | 57 | -9.52% |
| 31 Mar, 20 | 63 | -22.22% |
| 31 Dec, 19 | 81 | -10.99% |
| 30 Sep, 19 | 91 | -13.33% |
| 30 Jun, 19 | 105 | 10.53% |
| 31 Mar, 19 | 95 | 35.71% |
| 31 Dec, 18 | 70 | -14.63% |
| 30 Sep, 18 | 82 | -18.00% |
| 30 Jun, 18 | 100 | 17.65% |
| 31 Mar, 18 | 85 | 7.59% |
| 31 Dec, 17 | 79 | -4.82% |
| 30 Sep, 17 | 83 | 7.79% |
| 30 Jun, 17 | 77 | -19.79% |
| 31 Mar, 17 | 96 | 37.14% |
| 31 Dec, 16 | 70 | -39.66% |
| 30 Sep, 16 | 116 | 36.47% |
| 30 Jun, 16 | 85 | 30.77% |
| 31 Mar, 16 | 65 | -1.52% |
| 31 Dec, 15 | 66 | -4.35% |
| 30 Sep, 15 | 69 | -15.85% |
| 30 Jun, 15 | 82 | -2.38% |
| 31 Mar, 15 | 84 | 12.00% |
| 31 Dec, 14 | 75 | 102.70% |
| 30 Sep, 14 | 37 | -33.93% |
| 30 Jun, 14 | 56 | 3.70% |
| 31 Mar, 14 | 54 | 170.00% |
| 31 Dec, 13 | 20 | -16.67% |
| 30 Sep, 13 | 24 | 2300.00% |
| 30 Jun, 13 | 1 | - |
105 institutional shareholders have increased their position in ANIP stock as of 30 Jun 24 compared to 108 in the previous quarter (a -2.78% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 62 | 19.23% |
| 31 Mar, 24 | 52 | - |
| 31 Dec, 23 | 52 | 1.96% |
| 30 Sep, 23 | 51 | 121.74% |
| 30 Jun, 23 | 23 | -54.90% |
| 31 Mar, 23 | 51 | 50.00% |
| 31 Dec, 22 | 34 | -27.66% |
| 30 Sep, 22 | 47 | 42.42% |
| 30 Jun, 22 | 33 | -21.43% |
| 31 Mar, 22 | 42 | 55.56% |
| 31 Dec, 21 | 27 | -41.30% |
| 30 Sep, 21 | 46 | 15.00% |
| 30 Jun, 21 | 40 | -13.04% |
| 31 Mar, 21 | 46 | 2.22% |
| 31 Dec, 20 | 45 | 25.00% |
| 30 Sep, 20 | 36 | -16.28% |
| 30 Jun, 20 | 43 | -20.37% |
| 31 Mar, 20 | 54 | -5.26% |
| 31 Dec, 19 | 57 | -14.93% |
| 30 Sep, 19 | 67 | 34.00% |
| 30 Jun, 19 | 50 | -5.66% |
| 31 Mar, 19 | 53 | -17.19% |
| 31 Dec, 18 | 64 | 14.29% |
| 30 Sep, 18 | 56 | 33.33% |
| 30 Jun, 18 | 42 | -22.22% |
| 31 Mar, 18 | 54 | - |
| 31 Dec, 17 | 54 | 92.86% |
| 30 Sep, 17 | 28 | -42.86% |
| 30 Jun, 17 | 49 | 22.50% |
| 31 Mar, 17 | 40 | -23.08% |
| 31 Dec, 16 | 52 | 48.57% |
| 30 Sep, 16 | 35 | 2.94% |
| 30 Jun, 16 | 34 | -12.82% |
| 31 Mar, 16 | 39 | 8.33% |
| 31 Dec, 15 | 36 | -2.70% |
| 30 Sep, 15 | 37 | 8.82% |
| 30 Jun, 15 | 34 | 9.68% |
| 31 Mar, 15 | 31 | 47.62% |
| 31 Dec, 14 | 21 | 5.00% |
| 30 Sep, 14 | 20 | 5.26% |
| 30 Jun, 14 | 19 | 171.43% |
| 31 Mar, 14 | 7 | 133.33% |
| 31 Dec, 13 | 3 | - |
| 30 Sep, 13 | - | - |
| 30 Jun, 13 | - | - |
62 institutional shareholders have reduced their position in ANIP stock as of 30 Jun 24 compared to 52 in the previous quarter (a 19.23% increase).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 201 | -2.43% | 15,122,877 | 7.14% | 79.18% | 1.45% | 105 | -2.78% | 62 | 19.23% |
| 31 Mar, 24 | 206 | 12.57% | 14,115,555 | 3.76% | 73.91% | 1.44% | 108 | 25.58% | 52 | - |
| 31 Dec, 23 | 183 | -2.66% | 13,603,494 | 3.16% | 71.59% | 1.47% | 86 | -16.50% | 52 | 1.96% |
| 30 Sep, 23 | 188 | 8.67% | 13,186,506 | 7.85% | 69.83% | 1.46% | 103 | -11.97% | 51 | 121.74% |
| 30 Jun, 23 | 173 | 23.57% | 12,226,770 | 18.11% | 69.12% | 1.73% | 117 | 98.31% | 23 | -54.90% |
| 31 Mar, 23 | 140 | 10.24% | 10,351,783 | 1.13% | 63.15% | 1.59% | 59 | -11.94% | 51 | 50.00% |
| 31 Dec, 22 | 127 | 5.83% | 10,235,727 | -0.20% | 62.95% | 1.59% | 67 | 36.73% | 34 | -27.66% |
| 30 Sep, 22 | 120 | 5.26% | 10,256,276 | 3.95% | 62.91% | 1.71% | 49 | -16.95% | 47 | 42.42% |
| 30 Jun, 22 | 114 | -5.79% | 9,866,909 | 7.33% | 60.64% | 1.87% | 59 | -10.61% | 33 | -21.43% |
| 31 Mar, 22 | 121 | -8.33% | 9,192,939 | 2.77% | 56.97% | 1.13% | 66 | -21.43% | 42 | 55.56% |
| 31 Dec, 21 | 132 | 15.79% | 8,945,507 | 22.34% | 71.02% | 1.92% | 84 | 104.88% | 27 | -41.30% |
| 30 Sep, 21 | 114 | 0.88% | 7,312,182 | 1.37% | 60.84% | 1.70% | 41 | -18.00% | 46 | 15.00% |
| 30 Jun, 21 | 113 | 6.60% | 7,213,353 | -1.09% | 59.83% | 1.62% | 50 | 19.05% | 40 | -13.04% |
| 31 Mar, 21 | 106 | -9.40% | 7,293,187 | -0.88% | 60.76% | 1.61% | 42 | -22.22% | 46 | 2.22% |
| 31 Dec, 20 | 117 | 2.63% | 7,358,068 | 1.30% | 61.34% | 1.67% | 54 | -3.57% | 45 | 25.00% |
| 30 Sep, 20 | 114 | -13.64% | 7,263,569 | -2.22% | 60.58% | 1.57% | 56 | -1.75% | 36 | -16.28% |
| 30 Jun, 20 | 132 | -9.59% | 7,428,472 | -6.49% | 62.07% | 1.39% | 57 | -9.52% | 43 | -20.37% |
| 31 Mar, 20 | 146 | -16.57% | 7,943,670 | -1.62% | 66.85% | 1.45% | 63 | -22.22% | 54 | -5.26% |
| 31 Dec, 19 | 175 | -12.94% | 8,074,478 | -11.27% | 67.93% | 1.16% | 81 | -10.99% | 57 | -14.93% |
| 30 Sep, 19 | 201 | -0.99% | 9,100,263 | 6.31% | 76.61% | 1.47% | 91 | -13.33% | 67 | 34.00% |
| 30 Jun, 19 | 203 | 4.10% | 8,560,117 | 11.23% | 72.23% | 1.68% | 105 | 10.53% | 50 | -5.66% |
| 31 Mar, 19 | 195 | 14.71% | 7,695,772 | 8.68% | 65.51% | 1.80% | 95 | 35.71% | 53 | -17.19% |
| 31 Dec, 18 | 170 | -4.49% | 7,081,024 | -5.63% | 60.37% | 1.47% | 70 | -14.63% | 64 | 14.29% |
| 30 Sep, 18 | 178 | -6.32% | 7,503,783 | 4.31% | 64.10% | 1.69% | 82 | -18.00% | 56 | 33.33% |
| 30 Jun, 18 | 190 | 3.83% | 7,193,512 | 8.62% | 61.59% | 1.89% | 100 | 17.65% | 42 | -22.22% |
| 31 Mar, 18 | 183 | 7.02% | 6,622,753 | 1.20% | 57.15% | 1.78% | 85 | 7.59% | 54 | - |
| 31 Dec, 17 | 171 | 13.25% | 6,544,504 | 2.04% | 56.68% | 1.84% | 79 | -4.82% | 54 | 92.86% |
| 30 Sep, 17 | 151 | -5.63% | 6,413,750 | -1.28% | 55.52% | 1.75% | 83 | 7.79% | 28 | -42.86% |
| 30 Jun, 17 | 160 | -5.88% | 6,496,986 | 0.68% | 56.27% | 1.80% | 77 | -19.79% | 49 | 22.50% |
| 31 Mar, 17 | 170 | 2.41% | 6,453,161 | 3.28% | 55.98% | 1.90% | 96 | 37.14% | 40 | -23.08% |
| 31 Dec, 16 | 166 | -8.29% | 6,248,132 | 3.56% | 54.25% | 1.96% | 70 | -39.66% | 52 | 48.57% |
| 30 Sep, 16 | 181 | 21.48% | 6,033,557 | 7.58% | 52.63% | 2.18% | 116 | 36.47% | 35 | 2.94% |
| 30 Jun, 16 | 149 | 16.41% | 5,608,466 | -3.40% | 49.19% | 1.89% | 85 | 30.77% | 34 | -12.82% |
| 31 Mar, 16 | 128 | -1.54% | 5,805,959 | -8.13% | 50.95% | 1.66% | 65 | -1.52% | 39 | 8.33% |
| 31 Dec, 15 | 130 | 3.17% | 6,319,843 | -54.56% | 55.33% | 0.37% | 66 | -4.35% | 36 | -2.70% |
| 30 Sep, 15 | 126 | -4.55% | 13,907,641 | 114.14% | 122.17% | 3.73% | 69 | -15.85% | 37 | 8.82% |
| 30 Jun, 15 | 132 | -0.75% | 6,494,752 | -6.68% | 57.25% | 1.52% | 82 | -2.38% | 34 | 9.68% |
| 31 Mar, 15 | 133 | 30.39% | 6,959,440 | -13.31% | 61.45% | 1.14% | 84 | 12.00% | 31 | 47.62% |
| 31 Dec, 14 | 102 | 45.71% | 8,027,767 | 77.40% | 73.37% | 4.52% | 75 | 102.70% | 21 | 5.00% |
| 30 Sep, 14 | 70 | -11.39% | 4,525,293 | -0.52% | 40.28% | 2.46% | 37 | -33.93% | 20 | 5.26% |
| 30 Jun, 14 | 79 | 19.70% | 4,549,048 | 20.01% | 40.50% | 2.81% | 56 | 3.70% | 19 | 171.43% |
| 31 Mar, 14 | 66 | 94.12% | 3,790,590 | 190.23% | 37.94% | 5.72% | 54 | 170.00% | 7 | 133.33% |
| 31 Dec, 13 | 34 | 21.43% | 1,306,043 | 20.21% | 25.76% | 5.61% | 20 | -16.67% | 3 | - |
| 30 Sep, 13 | 28 | 2700.00% | 1,086,431 | 8232.80% | 21.42% | 20990.36% | 24 | 2300.00% | - | - |
| 30 Jun, 13 | 1 | - | 13,038 | - | 0.32% | - | 1 | - | - | - |
ANI Pharmaceuticals Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of ANI Pharmaceuticals's stock was made by Cook Meredith on Aug 14 2024, selling 250 shares at $59.62 per share (valued at $14.90K).
ANI Pharmaceuticals Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | - | 8 | - |
| Q2 2024 | 8 | 29 | 27.59% |
| Q1 2024 | 18 | 40 | 45.00% |
| Q4 2023 | - | 19 | - |
| Q3 2023 | 5 | 31 | 16.13% |
| Q2 2023 | 6 | 10 | 60.00% |
| Q1 2023 | 18 | 17 | 105.88% |
| Q4 2022 | - | 1 | - |
| Q3 2022 | 1 | 2 | 50.00% |
| Q2 2022 | 11 | 4 | 275.00% |
| Q1 2022 | 10 | 7 | 142.86% |
| Q4 2021 | 6 | - | - |
| Q3 2021 | - | 1 | - |
| Q2 2021 | - | 4 | - |
| Q1 2021 | 14 | 5 | 280.00% |
| Q4 2020 | 1 | - | - |
| Q3 2020 | 9 | - | - |
| Q2 2020 | 8 | 7 | 114.29% |
| Q1 2020 | 2 | 6 | 33.33% |
| Q3 2019 | - | 10 | - |
0 total buy trades, and 8 total sell trades (buy/sell ratio of 0.00%) were made by ANI Pharmaceuticals's insiders, as of Q3 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | - | 7 | - |
| Q2 2024 | - | 24 | - |
| Q1 2024 | - | 20 | - |
| Q4 2023 | - | 19 | - |
| Q3 2023 | - | 24 | - |
| Q2 2023 | - | 8 | - |
| Q1 2023 | - | - | - |
| Q4 2022 | - | 1 | - |
| Q3 2022 | - | 1 | - |
| Q2 2022 | - | - | - |
| Q1 2022 | 4 | - | - |
| Q4 2021 | 3 | - | - |
| Q3 2021 | - | - | - |
| Q2 2021 | - | - | - |
| Q1 2021 | 1 | - | - |
| Q4 2020 | 1 | - | - |
| Q3 2020 | 3 | - | - |
| Q2 2020 | - | - | - |
| Q1 2020 | 2 | - | - |
| Q3 2019 | - | 10 | - |
As of Q3 2024, Insider owners conducted 0 open market buy trades and 7 open market sell trades of ANI Pharmaceuticals's stocks.
ANI Pharmaceuticals Peer Ownership
| Ticker | Company |
|---|---|
| RDY | Dr. Reddy's Laboratories Limited |
| PAHC | Phibro Animal Health Corporation |
| NBIX | Neurocrine Biosciences, Inc. |
| IRWD | Ironwood Pharmaceuticals, Inc. |
| SSIC | Silver Spike Investment Corp. |
| INCR | InterCure Ltd. |
| DCPH | Deciphera Pharmaceuticals, Inc. |
| PROC | Procaps Group S.A. |
| PBH | Prestige Consumer Healthcare Inc. |
| ALKS | Alkermes plc |
| PCRX | Pacira BioSciences, Inc. |
| COLL | Collegium Pharmaceutical, Inc. |
| EGRX | Eagle Pharmaceuticals, Inc. |
| AMPH | Amphastar Pharmaceuticals, Inc. |
ANIP Ownership FAQ
Who Owns ANI Pharmaceuticals?
ANI Pharmaceuticals is owned by institutional shareholders (79.18%), insiders (11.16%), and public (9.66%). The largest institutional shareholder of ANI Pharmaceuticals is BLACKROCK INC. (13.91% of total shares) and the top mutual fund owner is Walthausen Funds (1.13% of total shares).
Who are the major institutional shareholders of ANI Pharmaceuticals?
ANI Pharmaceuticals's major institutional shareholders are BLACKROCK INC., VANGUARD GROUP INC, STATE STREET CORP, DIMENSIONAL FUND ADVISORS LP, and RUBRIC CAPITAL MANAGEMENT LP. The top five shareholders own together 31.29% of the company's share outstanding.
How many ANI Pharmaceuticals shareholders are there?
As of Jun 2024, there are 201 institutional shareholders of ANI Pharmaceuticals.
What percentage of ANI Pharmaceuticals is owned by BLACKROCK INC?
BLACKROCK INC owns 2.66M shares of ANI Pharmaceuticals, representing 13.91% of the company's total shares outstanding, valued at $169.17M (as of Jun 2024).
What percentage of ANI Pharmaceuticals is owned by VANGUARD GROUP INC?
As of Jun 2024, VANGUARD GROUP INC holds 1.44M shares of ANI Pharmaceuticals (ANIP), compromising 7.54% of the company, valued at $91.73M.
What percentage of ANI Pharmaceuticals is owned by STATE STREET CORP?
STATE STREET CORP is the third largest holder of ANI Pharmaceuticals. The company owns 645.14K of the company's shares outstanding (worth $41.08B).